Cargando…

P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination

Detalles Bibliográficos
Autores principales:	Gonzalez, LE, Strbo, N, Podack, ER
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767681/ http://dx.doi.org/10.1186/1742-4690-6-S3-P19

Ejemplares similares

OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
por: Strbo, N, et al.
Publicado: (2009)

Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice
por: Fisher, Eva, et al.
Publicado: (2021)

Complete prevention of HTLV-1 infection in humanized mice (hu-PBL SCID) by a neutralizing monoclonal antibody to envelope gp46
por: Saito, Mineki, et al.
Publicado: (2014)

Using human-severe combined immunodeficiency (hu-SCID) mice as a model for testing allergenicity of genetically modified organisms (GMOs)
por: Lee, R, et al.
Publicado: (2013)

P02.96. Effects of deep breathing on pulse pressure harmonics
por: Li, W, et al.
Publicado: (2012)

PA02.03. Pharmaceutical standardization of Ropya raj rasa
por: Agrawal, Sachin, et al.
Publicado: (2013)

P02-03. Screening of potential adjuvants for induction of pro-IgA factors
por: Buffa, V, et al.
Publicado: (2009)

P03-02 Benefits of play that include physical activity in preschoolers on their adaptive functioning
por: Gallardo, Rodrigo, et al.
Publicado: (2022)

PA03.02. The effect of bhumyamalaki (Phyllanthus Niruri) in balatisara with special reference to viral diarrhea
por: Kamatnur, Nabisab, et al.
Publicado: (2013)

P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein
por: Cranage, M, et al.
Publicado: (2009)

Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice
por: Stoddart, Cheryl A., et al.
Publicado: (2007)

Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses
por: Padula, Laura, et al.
Publicado: (2022)

P07-03. HIV gp120 interaction with CD4+ T cells induces local intracellular signaling and creates an F-actin depleted zone in the virological synapse
por: Vasiliver-Shamis, G, et al.
Publicado: (2009)

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
por: Tagliamonte, M, et al.
Publicado: (2009)

P02-10. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1
por: Kessans, SA, et al.
Publicado: (2009)

The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
por: Okada, Masaji, et al.
Publicado: (2005)

Long-term human hematopoiesis in the SCID-hu mouse
Publicado: (1990)

P03.02. From CAM practice to CAM research: a bridge fellowship for CAM practitioners to pursue careers in clinical research
por: Evans, R, et al.
Publicado: (2012)

P02.03. Decreased medication use and cost savings in inpatient oncology through a yoga-based integrative medicine approach
por: Friedman, J, et al.
Publicado: (2012)

Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID- hu mice after peripheral inoculation with HIV-1
Publicado: (1994)

P02-03 A systematic review and qualitative meta-synthesis of the context, barriers and facilitators to cross-sector collaboration promoting physical activity
por: Kolovou, Vasiliki, et al.
Publicado: (2022)

Thymic selection of the human T cell receptor V beta repertoire in SCID- hu mice
Publicado: (1992)

Rate and affinity binding constants determined by SPR spectroscopy reveal differential antigenicity of HIV gp120 and gp140
por: Gearhart, TL, et al.
Publicado: (2012)

P03.03. Facebook use and professionalism among CAM students
por: Hinck, G, et al.
Publicado: (2012)

PA03.03. Effect of manjishtadi lepa in management of ankle sprain
por: Patil, S Suraj, et al.
Publicado: (2013)

NMR spectroscopy of HIV-1 gp120 outer domain
por: Sastry, M, et al.
Publicado: (2012)

Anti-HIV and immune modulating activities of IND02
por: Biedma, ME, et al.
Publicado: (2012)

Nitric oxide protects against HIV gp120 endothelial injury
por: Fiorucci, S, et al.
Publicado: (2010)

P18-03. Dendritic cell-based immune therapy against HIV-1
por: Gruters, RA, et al.
Publicado: (2009)

Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras
Publicado: (1994)

GP96: safeguarding Treg
por: Zhang, Yongliang, et al.
Publicado: (2015)

OA03.02. Acupuncture for back pain: predicting attendance at appointments
por: Bishop, F, et al.
Publicado: (2012)

P1244: ROLE OF SELECT T HELPER CELL MONONUCLEAR CELL SUBSETS PROMOTING EPSTEIN-BARR VIRUS-DRIVEN LYMPHOPROLIFERATIVE DISEASE IN THE HU-PBL-SCID MODEL
por: Ahmed, E. H., et al.
Publicado: (2022)

Antigenicity of soluble HIV gp140 trimers reveals differences in solution conformation for differing HIV strains
por: Gearhart, TL, et al.
Publicado: (2012)

Length variation in HIV-1 gp120 as the product of DNA misalignment mechanism
por: Guglietta, Silvia, et al.
Publicado: (2010)

Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination
por: Sharma, SK, et al.
Publicado: (2012)

Antigen processing sites in gp120 are conserved across HIV virus clades
por: Yu, B, et al.
Publicado: (2012)

Virus-like particles highly expressing DC-SIGN concentrate trimeric HIV-envelope proteins with noncovalently linked immunoreactive gp120 and gp41
por: Vyas, GN
Publicado: (2012)

The impact of HLA-Cw*12:02 on control of HIV-1 infection
por: Koyanagi, M, et al.
Publicado: (2012)

P02-02. Analysis of antigen specific degranulation potentials using IL-12 or IL-28B during HIV DNA Vaccination
por: Morrow, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_698h09e10tq926l3gar3dkfer8